MICRONEEDLE NASAL DELIVERY DEVICE

• US 20130085472A1
• Filed: 03/09/2011
• Published: 04/04/2013
• Est. Priority Date: 03/09/2010
• Status: Abandoned Application

• Current Assignee: Toxcure LLC
• Original Assignee: Toxcure LLC
• Inventors: Shaari, Christopher
• Application Number:
  US13/583,446
• Publication Number:
  US 20130085472A1
• Time in Patent Office: Days
• US Class Current: 604/506
• CPC Class Codes: A61M 2025/105 having a balloon suitable for drug delivery, e.g. by using holes for delivery, drug coating or membranes
• CPC Class Codes: A61M 2037/0023 Drug applicators using microneedles
• CPC Class Codes: A61M 2037/003 having a lumen
• CPC Class Codes: A61M 2210/0618 Nose
• CPC Class Codes: A61M 2210/0681 Sinus (maxillaris)
• CPC Class Codes: A61M 25/10 Balloon catheters A61M25/0125 takes precedence; embolectomy A61B17/22032; retractors A61B17/02; inflatable balloons for placing stents or stent-grafts A61F2/958 ; stomach balloons for treatment of obesity A61F5/0003; oesophagal tubes A61J15/00
• CPC Class Codes: A61M 37/0015 by using microneedles
• CPC Class Codes: A61M 5/00 Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests vaccination appliances for veterinary use A61D1/025 ; tube connectors, tube couplings, valves or branch units specially adapted for medical use A61M39/00; containers specially adapted for medical or pharmaceutical purposes A61J1/00; combinations of vial and syringe for mixing or transferring their contents A61J1/20; holders for containers for collecting, storing or administering blood or medical fluids A61J1/16
• CPC Class Codes: A61M 5/3286 Needle tip design, e.g. for improved penetration

Abstract

The invention is directed to a nasal delivery device comprising one or more microneedles, and to methods of nasally administering a composition with a nasal delivery device comprising one or more microneedles. In certain embodiments, the nasal delivery device comprises a substrate for administration of a composition to the nasal and/or sinus mucosa, wherein the substrate is non-absorbent and comprises one or more microneedles. In some embodiments, the nasal delivery device comprises a reservoir comprising one or more therapeutic agents, wherein the reservoir is in fluid communication with one or more microneedles.

Claims

1. A nasal delivery device comprising a substrate suitable for administration of a composition to a nasal or sinus mucosa, wherein the substrate comprises one or more microneedles.

3. The nasal delivery device of claim 1, wherein the substrate is selected from the group consisting of:

cotton, a sponge, an inflatable balloon, a probe, a roller, and a polymeric silicone elastomer.

4. The nasal delivery device of claim 1, wherein the at least one or more microneedles are 150 micrometers or less in length.

5. The nasal delivery device of claim 1, wherein the nasal delivery device comprises a reservoir in fluid communication with the microneedle.

6. The nasal delivery device of claim 5, wherein the reservoir comprises an injection port.

7. The nasal delivery device of claim 5, wherein the device comprises a shaft.

10. The nasal delivery device of claim 6, wherein the injection port is suitable for attachment of a syringe.

12. The nasal delivery device of claim 1, wherein the one or more microneedles are porous.

13. The nasal delivery device of claim 1, wherein the substrate is cotton, wherein the cotton is attached to one end of a shaft, and the one or more microneedles are attached or integrated in the cotton.

14. The nasal delivery device of claim 1, wherein the substrate is non-absorbent, wherein the non-absorbent substrate is attached to one end of a shaft, and the one or more microneedles are attached or integrated in the non-absorbent substrate.

15. The nasal delivery device of claim 14, wherein the non-absorbent substrate is a roller.

16. The nasal delivery device of claim 15, wherein the roller is cylindrical and rotates freely relative to the shaft.

17. The nasal delivery device of claim 15, wherein the roller is partially cylindrical.

18. The nasal delivery device of claim 14, wherein the shaft comprises an injection port.

19. The nasal delivery device of claim 18, wherein the injection port is suitable for attachment of a syringe.

20. The nasal delivery device of claim 19, wherein the shaft comprises a hollow center tubing.

21. The nasal delivery device of claim 7 comprising an absorbent or non-absorbent substrate at one end of the shaft and an absorbent substrate at the opposite end of the shaft.

22. The nasal delivery device of claim 21, wherein the absorbent substrate is a sponge.

23. The nasal delivery device of claim 1, wherein the substrate is concaved, and the one or more microneedles are attached or integrated on one or both sides of the concave surface.

24. The nasal delivery device of claim 1, wherein the substrate is convex, and the one or more of microneedles are attached or integrated on one or both sides of the convex surface.

25. The nasal delivery device of claim 1, wherein the substrate is flat, and the one or more of microneedles are attached or integrated on one or both side of the flat surface.

27. The nasal delivery device of claim 5, wherein the substrate is cotton, wherein the cotton is attached to one end of a shaft, and the one or more microneedles are attached or integrated in the cotton, and wherein the shaft comprises a fenestrated central tubing in fluid communication with the reservoir and the one or more microneedles.

28. The nasal delivery device of claim 7, wherein the device comprises a shaft selected from the group consisting of:

a bendable shaft, a calibrated shaft, and a shaft with a raised barrier.

31. The nasal delivery device of claim 28, wherein the shaft is a shaft with a raised barrier, wherein the raised barrier is situated at most 2.5 cm from the end of the device comprising the substrate comprising one or more microneedles.

33. The nasal delivery device of claim 22, wherein the absorbent substrate is a polyvinyl alcohol sponge.

34. The nasal delivery device of claim 1, wherein the substrate is a polyvinyl alcohol sponge, wherein the one or more microneedles are attached or integrated onto one or both sides of the sponge.

36. The nasal delivery device of claim 34, wherein the polyvinyl alcohol sponge comprises a soft pliable plastic sheet, wherein the microneedles are attached or integrated onto the sheet.

37. The nasal delivery device of claim 1, comprising one or more compositions for administration to the nasal mucosa.

38. The nasal delivery device of claim 37, comprising the one or more compositions at predetermined dosages.

39. The nasal delivery device of claim 37, wherein the composition is selected from the group consisting of:

adreno corticosteroids, antibiotics, antimigraine drugs, antiviral drugs, cardiovascular drugs, central nervous system drugs, autonomic nervous system drugs, diagnostic drugs, histamine, antihistamines, narcotics, sex hormones, inorganic compounds, vitamins, peptides, polypeptides, and proteins.

41. The nasal delivery device of claim 37, wherein the composition is coated onto at least a portion of the one or more microneedles.

42. A method for the nasal administration of a composition, comprising:

(a) contacting a composition with a nasal delivery device of claim 1, wherein the nasal delivery device comprises a substrate suitable for administration of the composition to a nasal or sinus mucosal surface of a subject in need thereof, wherein the substrate comprises one or more microneedles, and wherein the composition coats at least a portion of the one or more microneedles of the device; and

(b) contacting the nasal delivery device of (a) with a nasal or sinus mucosal surface of the subject such that the one or microneedles penetrate at least a portion of the mucosal surface,

wherein the composition is nasally administered to the subject.

66. The method of claim 42, further comprising cleaning the nasal or sinus mucosal surface with an absorbent substrate located on the shaft at the end opposite the substrate comprising the one or more microneedles prior to contacting the surface with the one or more microneedles.

67. The method of claim 42, further comprising cleaning the nasal or sinus mucosal surface with a non-absorbent substrate located on the shaft at the end opposite the substrate comprising the one or more microneedles prior to contacting the surface with the one or more microneedles.

68. The method of claim 42, further comprising cleaning the nasal or sinus mucosal surface with an absorbent substrate located on the shaft at the end opposite the substrate comprising the one or more microneedles after contacting the surface with the one or more microneedles.

69. The method of claim 42, further comprising cleaning the nasal or sinus mucosal surface with a non-absorbent substrate located on the shaft at the end opposite the substrate comprising the one or more microneedles after contacting the surface with the one or more microneedles.

75. The method of claim 42, wherein the nasal or sinus mucosal surface mucosal surface is selected from the group consisting of:

nasal vestibule, turbinates, septum, lateral wall, middle meatus, superior meatus, inferior meatus, olfactory mucosa and epithelium, squamous lining, pseudostratified columnar epithelium, and neuroepithelium.

81. A method for the systemic delivery of a composition, comprising:

(a) contacting a composition with a nasal delivery device of claim 1, wherein the nasal delivery device comprises a substrate suitable for administration of the composition to a nasal or sinus mucosal surface of a subject in need thereof'"'"', wherein the substrate comprises one or more microneedles, and wherein the composition coats at least a portion of the one or more microneedles of the device; and

(b) contacting the nasal delivery device of (a) with a nasal or sinus mucosal surface of the subject, such that the one or microneedles penetrate at least a portion of the mucosal surface,

wherein the composition is systemically delivered to the subject.

84. A method for the CNS delivery of a composition, comprising:

(a) contacting a composition with a nasal delivery device of claim 1, wherein the nasal delivery device comprises a substrate suitable for administration of the composition to a nasal or sinus mucosal surface of a subject in need thereof, wherein the substrate comprises one or more microneedles, and wherein the composition coats at least a portion of the one or more microneedles of the device; and

(b) contacting the nasal delivery device of (a) with an olfactory mucosal surface of the subject, such that the one or microneedles penetrate at least a portion of the olfactory mucosal surface,

wherein the composition is delivered to the CNS of the subject.

86. A method for the nasal administration of a composition, comprising:

(a) applying a solution or gel comprising a composition to a nasal or sinus mucosal surface of a subject in need thereof;

(b) contacting the nasal or sinus mucosal surface of the subject with a nasal delivery device of claim 1, wherein the nasal delivery devices comprises a substrate, wherein the substrate is a roller and comprises one or more microneedles; and

(c) rolling the roller of the microneedle device such that the one or more microneedles penetrate at least a portion of the nasal or sinus mucosal surface of the subject,

wherein the composition is nasally administered to the subject.

2. (canceled)

8. (canceled)

9. (canceled)

11. The nasal delivery device of claim wherein the one or more microneedles are hollow.

26. (canceled)

29. (canceled)

30. (canceled)

32. (canceled)

35. (canceled)

40. (canceled)

43-65. -65. (canceled)

70-74. -74. (canceled)

77-80. -80. (canceled)

82. (canceled)

83. (canceled)

85. (canceled)